Risk factors that may influence the decision to pause treatment include: Being in the dose-escalation phase of GLP-1 therapy Experiencing active gastrointestinal symptoms (nausea, vomiting, bloating) Having known gastroparesis or other conditions affecting gastric emptying Taking concurrent medications that further delay gastric emptying (e.g., opioids) Undergoing procedures with higher aspiration risk (e.g., emergency surgery, airway surgery) If your anaesthetist or surgical team advises temporary cessation based on your individual risk assessment, the timing will depend on the specific medication: Daily injections (such as liraglutide): Typically paused 24 hours before surgery Weekly injections (such as semaglutide, dulaglutide): Often paused with the last dose given at least 7 days before surgery Oral semaglutide (Rybelsus): Usually paused 24 hours before surgery [4] However, these timings may vary according to local NHS Trust protocols and individual clinical assessment

Ethics declarations Conflict of interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper
Our IV Therapy Lounge is complete with phantom full-body massage chairs, comfy leather seating, heating pads, charging stations, and the best brain wave therapy, NuCalm, to recharge and reboot your brain health
Skin-related sensory changes, including dysesthesia and altered skin sensation, also fall here based on clinical trial data showing 1-3% incidence
In a highly litigious atmosphere, with several major compounding players opting not to test the limits of whats legally permissible, there will indeed be a significant subset of patients who struggle to find accessible, affordable meds
Then the surgeon looks for any problems with the foveal ligament